Effect of troglitazone on cyclosporine whole blood levels

被引:8
作者
Burgess, SJ [1 ]
Singer, GG [1 ]
Brennan, DC [1 ]
机构
[1] Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Pharm,Renal Div, St Louis, MO 63110 USA
关键词
D O I
10.1097/00007890-199807270-00024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:272 / 272
页数:1
相关论文
共 6 条
[1]  
Iwamoto Y, 1996, DIABETIC MED, V13, P365, DOI 10.1002/(SICI)1096-9136(199604)13:4<365::AID-DIA19>3.0.CO
[2]  
2-M
[3]   Effects of troglitazone - A new hypoglycemic agents in patients with NIDDM poorly controlled by diet therapy [J].
Iwamoto, Y ;
Kosaka, K ;
Kuzuya, T ;
Akanuma, Y ;
Shigeta, Y ;
Kaneko, T .
DIABETES CARE, 1996, 19 (02) :151-156
[4]  
Kumar S, 1996, DIABETOLOGIA, V39, P701
[5]   METABOLIC EFFECTS OF NEW ORAL HYPOGLYCEMIC AGENT CS-045 IN NIDDM SUBJECTS [J].
SUTER, SL ;
NOLAN, JJ ;
WALLACE, P ;
GUMBINER, B ;
OLEFSKY, JM .
DIABETES CARE, 1992, 15 (02) :193-203
[6]  
1997, MED LETT DRUGS THER, V39, P49